Financial concerns prompt sponsoring pharmaceutical company to halt international phase I studies. J Natl Cancer Inst 1994 Sep 07;86(17):1353
Date
09/07/1994Pubmed ID
8064897DOI
10.1093/jnci/86.17.1353Scopus ID
2-s2.0-0028767603 (requires institutional sign-in at Scopus site)Author List
Stoter G, Arnold AA, Kurzrock R, Rustin GJAuthor
Razelle Kurzrock MD Center Associate Director, Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
CanadaClinical Trials, Phase I as Topic
Drug Industry
International Cooperation
Multicenter Studies as Topic
Netherlands
United Kingdom
United States